GSK — GSK plc
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1131399 ·
United Kingdom
Last close
$48.17
Market Cap
$96.48B
52W High
$60.11
52W Low
$41.38
ADV30
3,046,208
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 7,629,000,000 | 5,754,000,000 | 2,293,000,000 | 1,737,000,000 | 62,869,000,000 | 3,442,000,000 | 45,447,000,000 |
| Dec 2025 | 8,618,000,000 | 5,961,000,000 | 1,506,000,000 | 636,000,000 | 61,118,000,000 | 3,150,000,000 | 45,162,000,000 |
| Sep 2025 | 8,547,000,000 | 6,289,000,000 | 2,593,000,000 | 2,013,000,000 | 61,339,000,000 | 3,296,000,000 | 45,587,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$8,331,000,000
Investing CF
$-4,719,000,000
Financing CF
$-4,048,000,000
CapEx
$-3,000,000,000
Dividends Paid
$-2,666,000,000
Buybacks
$-1,203,000,000
EPS Diluted TTM
$2.36
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$11,464,000,000
Inventory
$6,282,000,000
Receivables
—
ST Investments
$1,000,000
EBIT TTM
$6,594,000,000
Pretax Income TTM
$5,904,000,000
Interest Exp TTM
$690,000,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$33,202,999,296
EBITDA
$10,817,999,872
Free Cash Flow
$3,482,625,024
Enterprise Value
$111,147,458,560
Total Cash
$3,105,999,872
Total Debt
$18,293,000,192
Shares Out
2,002,805,623
Trailing EPS
$3.19
Book Value
$11.91
ROE
33.4%
ROA
10.0%
Div Yield
3.78%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 32,667,000,000 | 8,338,000,000 | 5,716,000,000 | 61,118,000,000 | 45,162,000,000 | 16,377,000,000 | 7,741,000,000 |
| Dec 2024 | 31,376,000,000 | 5,542,000,000 | 2,575,000,000 | 59,463,000,000 | 46,377,000,000 | 13,671,000,000 | 6,554,000,000 |
| Dec 2023 | 30,328,000,000 | 7,345,000,000 | 4,928,000,000 | 59,005,000,000 | 46,210,000,000 | 13,347,000,000 | 6,768,000,000 |
| Dec 2022 | 29,324,000,000 | 6,729,000,000 | 14,956,000,000 | 60,146,000,000 | 50,050,000,000 | 10,598,000,000 | 7,403,000,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$4.98
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $38.00 · spot: $48.17 · call volume: 724 · put volume: 38
Expected Move to 2027-01-15:
±$5.70
(11.83%) —
implied range
$42.47 –
$53.87
· ATM straddle on $47.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GLAXF | GSK plc | $96.13B | $24.00 | — |
| SNYNF | Sanofi | $96.05B | $80.17 | — |
| SNY | Sanofi | $98.79B | $41.23 | — |
| REGN | REGENERON PHARMACEUTICALS, INC. | $76.69B | $758.27 | — |
| NVO | NOVO NORDISK A S | $126.77B | $37.91 | — |
News headlines (Yahoo Finance, 1h cache)
Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies
2026-09-30 11:00 · Yahoo
GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciated
2026-09-29 11:30 · Yahoo
Berenberg Turns Bullish on GSK as its $750 Million Deal Adds to Pipeline Momentum
2026-09-24 23:08 · Yahoo
GSK Adds Another Cancer Drug in a $750 Million Deal. Is its Oncology Bet Getting Bigger?
2026-09-24 22:41 · Yahoo
GSK Bets on HUTCHMED to Expand its Multi-Billion-Dollar Oncology Opportunity
2026-09-24 20:59 · Yahoo
GSK Targets £40B Sales as Oncology Push and £1.9B Savings Plan Take Shape
2026-09-23 10:02 · Yahoo
ALK appoints Tina Abild Olesen as Executive Vice President for Corporate, Portfolio and Product Strategy
2026-09-21 09:00 · Yahoo
GSK Inks $750M Deal to Add Experimental Blood Cancer Therapy
2026-09-15 15:22 · Yahoo
GSK Cuts 641 Jobs in Vaccine Manufacturing Restructuring
2026-09-15 14:23 · Yahoo
GSK (LSE:GSK) The Latest Update Raises A Bigger Question
2026-09-30 11:13 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.